Can-Fite BioPharma Ltd.

CANF | AMEX

Price Alert Chart Builder DCF Calculator

$2.22

-$0.02 (-0.89%)

At close: Sep 21, 2026, 4:00 PM ET

$2.26

+$0.04 (+1.74%)

Pre-market: Sep 22, 2026, 5:28 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	5.53M	4.83M	4.28M	2.98M	4.39M	8.27M
Short-Term Investments	3.01M	3.06M	4.64M	5M	14.75M	75K
Long-Term Investments	n/a	n/a	n/a	8K	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	-8K	n/a	n/a
Receivables	74K	n/a	n/a	47K	48K	18K
Inventory	n/a	n/a	n/a	-39K	-48K	n/a
Other Current Assets	825.99K	1.1M	78K	47K	48K	n/a
Total Current Assets	9.44M	8.98M	9.91M	9.16M	20.07M	9.4M
Property-Plant & Equipment	74K	138K	81K	126K	185K	123K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	74K	138K	81K	126K	185K	123K
Total Assets	9.51M	9.12M	9.99M	9.28M	20.25M	9.52M
Account Payables	1.16M	618K	427K	896K	954K	561K
Deferred Revenue	404.99K	405K	622K	783K	818K	334K
Short-Term Debt	56K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	298K	675K	694K	492K	603K	96K
Total Current Liabilities	2.73M	2.05M	2.02M	2.5M	2.73M	1.27M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	2.3M	3.07M	2.16M
Total Long-Term Liabilities	1.19M	1.63M	1.73M	2.31M	3.14M	2.18M
Total Liabilities	3.92M	3.68M	3.75M	4.81M	5.87M	3.45M
Total Debt	71K	104K	40K	62K	124K	67K
Book Value	5.59M	5.44M	6.24M	4.47M	14.38M	6.07M
Book Value Per Share	6.79	0.75	1.47	1.64	7.80	5.08
Common Stock	n/a	n/a	n/a	n/a	60.65M	33.04M
Retained Earnings	-176.19M	-166.36M	-158.48M	-150.85M	-140.67M	-125.47M
Comprehensive Income	1.13M	1.13M	1.13M	1.13M	1.13M	1.13M
Shareholders Equity	5.59M	5.44M	6.24M	4.47M	14.38M	6.07M
Total Investments	3.01M	3.06M	4.64M	5.01M	14.75M	75K